RT Journal Article
SR Electronic
T1 Moderate to vigorous physical activity and sedentary behavior change in self-isolating adults during the COVID-19 pandemic in Brazil: A cross-sectional survey exploring correlates
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.15.20154559
DO 10.1101/2020.07.15.20154559
A1 Schuch, Felipe B.
A1 Bulzing, Rugero A.
A1 Meyer, Jacob
A1 López-Sánchez, Guillermo F.
A1 Grabovac, Igor
A1 Willeit, Peter
A1 Vancampfort, Davy
A1 Caperchione, Cristina M.
A1 Sadarangani, Kabir P.
A1 Werneck, André O.
A1 Ward, Philip B.
A1 Tully, Mark
A1 Smith, Lee
YR 2020
UL http://medrxiv.org/content/early/2020/07/16/2020.07.15.20154559.abstract
AB Background Self-distancing measures imposed major changes in daily life. This study aimed to (i) evaluate the changes (pre-versus during pandemic) in time spent in moderate to vigorous physical activity (MVPA) and sedentary behavior (SB) in self-isolating Brazilians during the COVID-19 pandemic, and (ii) to explore correlates of MVPA and SB.Methods A cross-sectional self-report online survey, evaluating the time spent in MVPA and SB pre and during the COVID-19 pandemic. Sociodemographic, behavioral, clinical, variables, and time in self-isolation were also obtained. Changes in MVPA and SB and their correlates were explored using generalized estimating equations (GEE).Results A total of 877 participants (72.7% women, 53.7% young adults [18-34 years]) were included. Overall, participants reported a 59.7% reduction (95%CI:35.6 to 82.2) in time spent on MVPA during the pandemic. Time spent in SB increased 42.0% (95%CI:31.7 to 52.5). Greater reductions in MVPA and/or increases in SB were seen in younger adults, those not married, those employed and those with a self-reported previous diagnosis of a mental disorder.Conclusions People in self-isolation significantly reduced MVPA levels and increased SB. Public health strategies should be implemented during epidemic times to mitigate the impact of self-isolation on MVPA and SB, particularly in vulnerable groups.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was part financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. Andre Werneck is supported by a Sao Paulo Research Foundation PhD scholarship (FAPESP process: 2019/24124-7). Joseph Firth is supported by a University of Manchester Presidential Fellowship (P123958) and a UK Research and Innovation Future Leaders Fellowship (MR/T021780/1). Brendon Stubbs is supported by a Clinical Lectureship (ICA-CL-2017-03-001) jointly funded by Health Education England (HEE) and the National Institute for Health Research (NIHR). Brendon Stubbs is part funded by the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the (partner organisation), the NHS, the NIHR or the Department of Health and Social Care. Mark Tully is partly supported by funding as Director of the Northern Ireland Public Health Research Network by the Research and Development Division of the Public Health Agency (Northern Ireland).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Federal University of Santa Maria Research Ethics Committee and by the National Commission of Ethics in Research [CONEP] (30244620.1.0000.5346).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request.